[Characteristics of the action of medicinal substances on the fetus at various periods of intrauterine development].
D000014:Abnormalities, Drug-Induced; D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000925:Anticoagulants / Q000009:adverse effects; D000963:Antimetabolites / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D004357:Drug Synergism; D010064:Embryo Implantation; D005260:Female; D005333:Fetus / Q000187:drug effects*; D005865:Gestational Age; D005938:Glucocorticoids / Q000009:adverse effects; D006801:Humans; D011247:Pregnancy; D013792:Thalidomide / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D000963:Antimetabolites; D000970:Antineoplastic Agents; D005938:Glucocorticoids; D013792:Thalidomide
Osobennosti deĭstviia lekarstvennykh veshchestv na plod v razlichnye periody vnutriutrobnogo razvitiia.